Econic Biosciences

Econic Biosciences is a drug discovery biotech developing therapies that target extrachromosomal DNA, a circular form of DNA found outside normal chromosomes that drives oncogene amplification, tumour evolution, and treatment resistance across multiple cancer types.

The company uses AI to identify and characterise ecDNA and design specific therapeutic approaches, building on research establishing ecDNA as a primary mediator of oncogenic amplification and poor clinical outcomes.